# FewerJobs export - 100 curated jobs
Generated: 2026-08-12T18:59:52.999Z
Source: https://fewerjobs.com

## Filters applied
- **q**: Sarepta Therapeutics
- **quality_floor**: all
- **match_401k_strict**: true
- **parental_strict**: true
- **non_birth_strict**: true
- **pto_strict**: true
- **include_older**: false
- **apply_url_verified**: false
- **page**: 1
- **per_page**: 100
- **sort**: relevance

## Jobs
### Vice President, Global Pharmacovigilance - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-20
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Executive-Medical-Director--Pharmacovigilance_R-03155-1
- Excerpt: Vice President, Global Pharmacovigilance Cambridge, MA posted: Posted 23 Days Ago

### Senior Director, Quantitative & Clinical Pharmacology - Sarepta Therapeutics
- Location: 15 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Senior-Director--Quantitative---Clinical-Pharmacology_R-03128-1
- Excerpt: Senior Director, Quantitative & Clinical Pharmacology 15 Locations posted: Posted 30+ Days Ago

### Senior Director, Analytical Development, Separation Science and Protein Chemistry - Sarepta Therapeutics
- Location: Bedford, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-03
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Bedford-MA/Senior-Director--Analytical-Development--Separation-Science-and-Protein-Chemistry_R-03183-1
- Excerpt: Senior Director, Analytical Development, Separation Science and Protein Chemistry Bedford, MA posted: Posted 9 Days Ago

### Scientist II, Translational Biology - Sarepta Therapeutics
- Location: Columbus, OH (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-29
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Columbus-OH/Scientist-II--Translational-Biology_R-03201-1
- Excerpt: Scientist II, Translational Biology Columbus, OH posted: Posted 14 Days Ago

### Senior Scientist, Developability & Preformulation - Sarepta Therapeutics
- Location: Columbus, OH (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Columbus-OH/Senior-Scientist--Developability---Preformulation_R-03188
- Excerpt: Senior Scientist, Developability & Preformulation Columbus, OH posted: Posted 30+ Days Ago

### Associate Director, Quantitative Clinical Pharmacology - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Associate-Director--Quantitative-Clinical-Pharmacology_R-03180-1
- Excerpt: Associate Director, Quantitative Clinical Pharmacology Cambridge, MA posted: Posted 30+ Days Ago

### Senior Director, Process Development, RNA & Small Molecule Therapies - Sarepta Therapeutics
- Location: 2 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Bedford-MA/Senior-Director--RNA---Small-Molecule-Therapies_R-03220-1
- Excerpt: Senior Director, Process Development, RNA & Small Molecule Therapies 2 Locations posted: Posted Today

### Director, Analytical Development - Sarepta Therapeutics
- Location: Bedford, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-02
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Bedford-MA/Director--Analytical-Development_R-03215-1
- Excerpt: Director, Analytical Development Bedford, MA posted: Posted 10 Days Ago

### Associate Director, Global Program Management - Sarepta Therapeutics
- Location: Columbus, OH (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-16
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Columbus-OH/Associate-Director--Global-Program-Management_R-03202-1
- Excerpt: Associate Director, Global Program Management Columbus, OH posted: Posted 27 Days Ago

### Director, Market Access Marketing - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Director--Market-Access-Marketing_R-03198-1
- Excerpt: Director, Market Access Marketing Cambridge, MA posted: Posted Today

### Director, State Government Affairs - Sarepta Therapeutics
- Location: Atlanta, GA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Atlanta-GA/Director--State-Government-Affairs_R-03174
- Excerpt: Director, State Government Affairs Atlanta, GA posted: Posted 30+ Days Ago

### Associate Director, HR Business Partner - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Associate-Director--HR-Business-Partner_R-03199-1
- Excerpt: Associate Director, HR Business Partner Cambridge, MA posted: Posted 30+ Days Ago

### Associate Director, Clinical Operations Lead, Study Start-up & Feasibility - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-24
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Associate-Director--Clinical-Operations-Lead--Study-Start-up---Feasibility_R-03208-1
- Excerpt: Associate Director, Clinical Operations Lead, Study Start-up & Feasibility Cambridge, MA posted: Posted 19 Days Ago

### Associate Engineer, RNA Starting Material MS&T - Sarepta Therapeutics
- Location: Andover, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-16
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Andover-MA/Associate-Engineer--RNA-Starting-Material-MS-T_R-03200-1
- Excerpt: Associate Engineer, RNA Starting Material MS&T Andover, MA posted: Posted 27 Days Ago

### Associate Director, IT Validation - Sarepta Therapeutics
- Location: Andover, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Andover-MA/Associate-Director--IT-Validation_R-03184-1
- Excerpt: Associate Director, IT Validation Andover, MA posted: Posted 30+ Days Ago

### Director, Commercial Training & Capabilities - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-10
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Director--Commercial-Training---Capabilities_R-03171-1
- Excerpt: Director, Commercial Training & Capabilities Cambridge, MA posted: Posted 2 Days Ago

### Associate Director, Regulatory Information Management Systems - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-09
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Senior-Manager--Regulatory-Operations_R-03176-1
- Excerpt: Associate Director, Regulatory Information Management Systems Cambridge, MA posted: Posted 3 Days Ago

### Senior Director, Biostatistics - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-25
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Senior-Director--Biostatistics_R-03206-1
- Excerpt: Senior Director, Biostatistics Cambridge, MA posted: Posted 18 Days Ago

### Lead Data Manager, Clinical Data Management - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-05
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Lead-Data-Manager--Clinical-Data-Management_R-03182-1
- Excerpt: Lead Data Manager, Clinical Data Management Cambridge, MA posted: Posted 7 Days Ago

### Duchenne Nurse Educator - Sarepta Therapeutics
- Location: 2 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/New-York-NY/Duchenne-Nurse-Educator_R-03197-2
- Excerpt: Duchenne Nurse Educator 2 Locations posted: Posted 30+ Days Ago

### Senior Cost Accountant - Sarepta Therapeutics
- Location: Bedford, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Bedford-MA/Senior-Accountant_R-03147-1
- Excerpt: Senior Cost Accountant Bedford, MA posted: Posted 30+ Days Ago

### Director, Biostatistics - Sarepta Therapeutics
- Location: Cambridge, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-24
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Director--Biostatistics_R-03207
- Excerpt: Director, Biostatistics Cambridge, MA posted: Posted 19 Days Ago

### Duchenne Nurse Educator - Sarepta Therapeutics
- Location: 2 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-05
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Los-Angeles-CA/Duchenne-Nurse-Educator_R-03062-1
- Excerpt: Duchenne Nurse Educator 2 Locations posted: Posted 7 Days Ago

### MSL Team Lead - US East - Sarepta Therapeutics
- Location: 4 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-27
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/MSL-Team-Lead---US-East_R-03210-1
- Excerpt: MSL Team Lead - US East 4 Locations posted: Posted 16 Days Ago

### Law Clerk Co-op - Sarepta Therapeutics
- Location: 2 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-27
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Cambridge-MA/Law-Clerk-Co-op_R-03213
- Excerpt: Law Clerk Co-op 2 Locations posted: Posted 16 Days Ago

### Senior Director, Clinical Development - Definium Therapeutics
- Location: Remote (remote)
- Salary: $248K-$299K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5808053004
- Excerpt: Senior Director, Clinical Development Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! The Sr. Director, Clinical Development will play a key role in the design and execution of ongoing and new clinical studies and contribute to the clinical development plan for one or more programs. The position will successfully lead and/or serve as the clinical science representative on one or more clinical studies (US and/or global) to deliver high quality data for registration. The position requires the

### Associate Director, Clinical Development - Definium Therapeutics
- Location: Remote (remote)
- Salary: $170K-$192K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5977186004
- Excerpt: Associate Director, Clinical Development Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! The Associate Director, Clinical Development plays a key role in the design and execution of ongoing and new clinical development studies. This position serves as the clinical science representative on one or more U.S. and/or global clinical studies and contributes to the delivery of high‑quality clinical data to support registration and launch. The role partners cross‑functionally with Clinical Operations, Clinical Pharmacology, Regulatory Affairs, Early Development,

### Senior Clinical Trial Associate - Rapport Therapeutics Inc
- Location: 99 High Street, Suite 2100 , Boston, MA 02110 (unspecified)
- Salary: $90K-$110K
- Posted: 2026-04-22
- Apply: https://www.rapportrx.com/careers-board/?gh_jid=5001441007
- Excerpt: Senior Clinical Trial Associate 99 High Street, Suite 2100 , Boston, MA 02110 When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we're driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we're doing this with extraordinary science and awesome people (affectionately called Rapptors). Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials for neuropathic pain and bipolar disorder. The strength of Rapport comes from our Rapptors - who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you're as excited about this opportunity as we are! Your impact: As a Senior Clinical Trial Associate, you'll be a key player in keeping our clinical studies on track-managing the details, supporting the team, and helping bring innovative treatments to patients Your day-to-day: - Coordinates and tracks the distribution and subsequent retrieval of clinical documents, including but not limited to

### Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) (Vollzeit, unbefristet) - AbbVie Inc.
- Location: Ludwigshafen, RP, Germany (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-10
- Parental leave: 12 weeks (not source-backed)
- Non-birth-parent leave: 12 weeks (not source-backed)
- 401(k) match: listed (not source-backed)
- Apply: https://jobs.smartrecruiters.com/AbbVie/3743990012977056-chemielaborant-pharmakant-chemikant-pta-cta-bta-fur-die-herstellung-parenteraler-klinischer-prufpraparate-all-genders-vollzeit-unbefristet-
- Excerpt: Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) (Vollzeit, unbefristet) Ludwigshafen, RP, Germany Unternehmensbeschreibung: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Stellenbeschreibung: Herzlich willkommen bei Abbvie! Als Teil eines internationalen Unternehmens mit über 48.000 Mitarbeitern weltweit und rund 3.000 Mitarbeitern in Deutschland hast Du die Möglichkeit, eng mit uns zusammenzuarbeiten, um die gesundheitlichen Herausforderungen von morgen zu meistern. Du hast eine Leidenschaft für die Verbesserung der Gesundheitsversorgung auf der ganzen Welt? Du möchtest Dein Fachwissen einsetzen, um die Lebensqualität von Patienten zu verbessern? In einem herausfordernden Arbeitsumfeld, das Dir die Möglichkeit bietet, Deine eigenen Fähigkeiten zu erweitern und zu entwickeln? Dann bist Du bei uns richtig! Gemeinsam großes bewegen - als Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) Für unser motiviertes und engagiertes Team in der Entwicklung und Herstellung von parenteralen Arzneiformen suchen wir tatkräftige Unterstützung. Routine ist uns fremd, da unsere Abteilung an innovativen Prozessen und Produkten für klinische Studien arbeitet und einen reibungslosen Transfer aus der Entwicklung in die Herstellung klinischer Prüfpräparate gewährleistet. Unsere Aufgaben und Chargengrößen passen sich den jeweiligen Forschungs- und Entwicklungsprojekten

### Senior Medical Director Clinical Development Neuroscience - Arvinas Inc
- Location: Remote, Hybrid, New Haven - CT (hybrid)
- Salary: Not disclosed
- Posted: 2026-04-10
- Hires in: CT
- Apply: https://job-boards.greenhouse.io/arvinas/jobs/7696313003
- Excerpt: Senior Medical Director Clinical Development Neuroscience Remote, Hybrid, New Haven - CT Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. On August 8 th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development

### Associate Director, Biostatistics - Definium Therapeutics
- Location: Remote (remote)
- Salary: $184K-$209K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5848284004
- Excerpt: Associate Director, Biostatistics Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! As an Associate Director, Biostatistics this person will provide statistical support for pipeline compounds' clinical development, regulatory filing, and commercialization. Reporting to Vice President, Head of Biometrics and Data Science, the successful candidate will serve as the biostatistician for assigned clinical trials to provide statistical leadership from trial design, data analysis, to results interpretation and dissemination. This role will also provide statistical support to regulatory filing

### Senior Director, Marketing - Definium Therapeutics
- Location: Remote (remote)
- Salary: $252K-$295K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5985751004
- Excerpt: Senior Director, Marketing Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! Definium Therapeutics, formerly known as Mind Medicine, is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key

### Senior Clinical Trial Associate - Olema Pharmaceuticals
- Location: San Francisco, California (unspecified)
- Salary: $110K-$120K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/olema/jobs/5842651004
- Excerpt: Senior Clinical Trial Associate San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Senior Clinical Trial Associate As the Senior Clinical Trial Associate reporting to the Senior Manager, Clinical Trial Leader, you will provide comprehensive administrative and operational support to clinical team members across all study activities, including both in-house and outsourced trials. This role supports cross-functional study execution through coordination with internal teams, external vendors, and site staff, and may include contributing to study documentation such as informed consent forms (ICFs) and central IRB submissions, supporting site payments and other study-related operational activities, as well as liaising with and following up with investigator sites. Responsibilities include assisting with study start-up, maintenance, and closeout activities; managing study documentation and

### Senior Manager, Cost Accounting & Manufacturing Operations - Sarepta Therapeutics
- Location: Bedford, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://sarepta.wd5.myworkdayjobs.com/sarepta_external/job/Bedford-MA/Senior-Manager--Finance-----Inventory---Manufacturing-Operations_R-03066-1
- Excerpt: Senior Manager, Cost Accounting & Manufacturing Operations Bedford, MA posted: Posted 30+ Days Ago

### Senior Director, Medical Affairs Operations and Strategy - Definium Therapeutics
- Location: Remote (remote)
- Salary: $269K-$295K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5973783004
- Excerpt: Senior Director, Medical Affairs Operations and Strategy Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! Responsibilities: In collaboration with Medical Affairs leadership, develop, operationalize, and continuously refine the Medical Affairs strategy, helping to translate strategic objectives into actionable project plans, KPIs and timelines Oversee and ensure the quality of the departmental strategic planning processes, including operations tasks, and other activities related to pipeline compounds Leads organization, updating and communication of strategic plans to internal and external stakeholders

### DMPK Scientist - Arvinas Inc
- Location: Remote, Hybrid, New Haven - CT (hybrid)
- Salary: Not disclosed
- Posted: 2026-05-06
- Apply: https://job-boards.greenhouse.io/arvinas/jobs/7725520003
- Excerpt: DMPK Scientist Remote, Hybrid, New Haven - CT Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. On August 8 th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the

### Vice President, Pharmaceutical Development - Kymera Therapeutics Inc
- Location: Watertown, MA (unspecified)
- Salary: $315K-$395K
- Posted: 2026-05-26
- 401(k) match: listed (not source-backed)
- Apply: https://www.kymeratx.com/careers-culture/working-at-kymera/?gh_jid=7748334003#open-positions
- Excerpt: Vice President, Pharmaceutical Development Watertown, MA Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: - PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines. - COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you'll make an impact: - Define and lead the company's pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines - Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs - Champion innovation in formulation sciences and enabling technologies to

### Director of Process Validation - Viking Therapeutics
- Location: Viking Therapeutics, Inc. (unspecified)
- Salary: Not disclosed
- Posted: 2026-04-09
- Apply: https://recruiting.paylocity.com/Recruiting/Jobs/Details/4075036
- Excerpt: Director of Process Validation Viking Therapeutics, Inc. Director of Process Validation

### Early Development Team Leader - Arvinas Inc
- Location: Remote, Hybrid, New Haven - CT (hybrid)
- Salary: Not disclosed
- Posted: 2026-04-01
- Hires in: CT
- Apply: https://job-boards.greenhouse.io/arvinas/jobs/7686687003
- Excerpt: Early Development Team Leader Remote, Hybrid, New Haven - CT Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: ARV-102 for the treatment of patients with neurodegenerative disorders,ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas, and ARV-806, a KRAS G12D PROTAC for the treatment patients with solid tumors with KRAS G12D mutations. On August 8 th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical

### Medicinal Chemist - Inductive Bio
- Location: New York City, San Francisco, or Boston, United States (unspecified)
- Salary: Not disclosed
- Posted: 2026-04-20
- Apply: https://jobs.ashbyhq.com/inductive-bio/d6ef5aca-c6cf-4b82-b710-cf20e3bd2327
- Excerpt: Medicinal Chemist New York City, San Francisco, or Boston, United States Inductive Bio is an AI medicinal chemistry partner . We build virtual labs that help drug discovery teams make better decisions, faster, across the full DMTA cycle. Our platform includes Beacon-1 ADMET prediction models, human dose projection tools, and Indy, an AI medicinal chemistry assistant. Through partnerships with CROs, we also offer innovative synthesis approaches, direct-to-dose testing, and cost-effective tier 1 ADME panels that enable initial human PK projection, closing the loop from computational design to experimental validation. Together, these power dozens of small molecule and beyond-rule-of-five programs for biotech and pharma partners. Beacon-1 placed 1st in both the 2025 Polaris and 2026 OpenADMET-ExpansionRx blind competitions, ahead of Merck & Co + NVIDIA and EMD Serono. We've raised $30M from Obvious Ventures, a16z Bio + Health, and Lux Capital, and were selected for a $21M ARPA-H CATALYST award to develop next-generation toxicity models. We are seeking an accomplished Medicinal Chemist to play a key role in building an AI-forward drug discovery platform that impacts all stages of the Design-Make-Test-Analyze cycle, and deploy that platform to dozens of programs across the industry! This role will report directly to our Head of Medicinal Chemistry. What you'll do: - Be an embedded expert, supporting a variety of partner drug discovery programs from lead generation through development candidate nomination across diverse small molecule modalities. - Alongside outstanding compchem, DMPK, and machine learning colleagues, bring Inductive's tools and your medchem knowledge to our work

### Drug Safety Manager - Viking Therapeutics
- Location: Viking Therapeutics, Inc. (unspecified)
- Salary: Not disclosed
- Posted: 2026-03-19
- Apply: https://recruiting.paylocity.com/Recruiting/Jobs/Details/4014908
- Excerpt: Drug Safety Manager Viking Therapeutics, Inc. Drug Safety Manager

### Senior Director/Executive Director, Head of GCP Quality Assurance - Nkarta Inc
- Location: Remote (remote)
- Salary: $250K-$340K
- Posted: 2026-03-07
- Mental health support: yes (not source-backed)
- Apply: https://job-boards.greenhouse.io/nkartatherapeutics/jobs/5146532008
- Excerpt: Senior Director/Executive Director, Head of GCP Quality Assurance Remote About Us Nkarta is a publicly traded (Nasdaq symbol NKTX), clinical-stage biotechnology company headquartered in South San Francisco, focused on advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease. Founded in 2015, Nkarta is on a mission to harness the body's natural killer cells - the immune system's first responders - to deliver a safe, accessible form of cell therapy to treat B cell-mediated autoimmune diseases. Our vision is to make cell therapy more broadly available to patients by pioneering allogeneic NK cells that can be dosed in outpatient, community health settings. Nkarta's engineering process enhances the natural ability of NK cells to fight disease by identifying and eliminating unhealthy cells, including malfunctioning B cells at the root of many autoimmune conditions. Our lead NK cell therapy candidate, NKX019, uses NK cells collected from healthy donors rather than burdening the patient with a blood collection. Using donor-derived cells allows us to develop CAR NK cells off the shelf and on demand. Nkarta is a people-driven company looking for passionate, collaborative, determined team members galvanized by a paradigm-shifting opportunity to change the cell therapy landscape. Overview The Senior Director / Executive Director, Head of GCP Quality Assurance oversees GCP activities at Nkarta, our CROs and Investigator Sites, leads GCP audits and inspection readiness. The successful hire will ensure high quality execution of clinical trials from first in human through commercial marketing authorization by Health Authorities for

### Clinical Trial Manager - Viking Therapeutics
- Location: Viking Therapeutics, Inc. (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-11
- Apply: https://recruiting.paylocity.com/Recruiting/Jobs/Details/3913773
- Excerpt: Clinical Trial Manager Viking Therapeutics, Inc. Clinical Trial Manager

### Senior Manager, Biomarker Development - Tango Therapeutics Inc
- Location: Boston, MA (unspecified)
- Salary: $144K-$216K
- Posted: 2026-04-13
- 401(k) match: listed (not source-backed)
- Apply: https://job-boards.greenhouse.io/tangotherapeutics/jobs/7691065003
- Excerpt: Senior Manager, Biomarker Development Boston, MA Company Overview Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts Summary Tango Therapeutics has an exciting new opportunity for an experienced and innovative translational scientist in our Translational Medicine Team, to lead clinical biomarker development, in vitro diagnostic and companion diagnostic activities in support of ongoing clinical trials. This role will drive cross functional collaboration among discovery biologists, translational scientists, clinical operations, data management, regulatory, clinical compliance and quality groups to deliver biomarker insights to clinical development teams. Additionally, this position will administer operational aspects of clinical biomarker assays in clinical trials, including management of internal and external translational collaborations, third party laboratories and other clinical partners. Your Role - Oversee design, development, validation, verification and implementation of translational and clinical-grade biomarker assays to inform essential clinical research questions - Compile clinical biomarker assay data, conduct in-stream analyses, and package those translational insights for communication to key

### Medical Science Liaison Director/Lead - Viking Therapeutics
- Location: Viking Therapeutics, Inc. (unspecified)
- Salary: Not disclosed
- Posted: 2026-04-27
- Apply: https://recruiting.paylocity.com/Recruiting/Jobs/Details/4116882
- Excerpt: Medical Science Liaison Director/Lead Viking Therapeutics, Inc. Medical Science Liaison Director/Lead

### Associate Director, Formulation Development - Viking Therapeutics
- Location: Viking Therapeutics, Inc. (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-11
- Apply: https://recruiting.paylocity.com/Recruiting/Jobs/Details/4079847
- Excerpt: Associate Director, Formulation Development Viking Therapeutics, Inc. Associate Director, Formulation Development

### Director, Biostatistics - Tango Therapeutics Inc
- Location: Boston, MA (unspecified)
- Salary: $191K-$287K
- Posted: 2026-05-08
- 401(k) match: listed (not source-backed)
- Apply: https://job-boards.greenhouse.io/tangotherapeutics/jobs/7728858003
- Excerpt: Director, Biostatistics Boston, MA Company Overview Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. The Tango labs and offices are located at 201 Brookline Avenue, in the Fenway area of Boston, Massachusetts. Summary In this new role, reporting to the Vice President, Biometrics you will be working with cross‑functional clinical teams responsible for statistical activities across Tango's clinical programs, including overseeing statistical deliverables outsourced to clinical CROs. This is an exciting opportunity to make an impact in the development of transformative therapies that may change patients' lives. You will be a good communicator, collaborative, self-motivated, and forward‑thinking. Your Role: - You will serve as a biostatistics expert for Tango's clinical programs - Provide strategic input to optimize trial designs in early phase dose escalation studies and late phase registrational studies - As a biostatistics representative, proactively collaborate with internal and external CRO team members to coordinate the planning and execution of statistical deliverables - Conduct statistical modeling to enable robust and efficient statistical designs and address identified or potential statistical issues

### Senior/Executive Director, Health Economics & Outcomes Research (HEOR) - Viking Therapeutics
- Location: Viking Therapeutics, Inc. (unspecified)
- Salary: Not disclosed
- Posted: 2026-04-29
- Apply: https://recruiting.paylocity.com/Recruiting/Jobs/Details/4127771
- Excerpt: Senior/Executive Director, Health Economics & Outcomes Research (HEOR) Viking Therapeutics, Inc. Senior/Executive Director, Health Economics & Outcomes Research (HEOR)

### Director, Clinical Quality Assurance - Corcept Therapeutics
- Location: Redwood City, California, United States (unspecified)
- Salary: $229K-$260K
- Posted: 2026-05-13
- 401(k) match: listed (not source-backed)
- Apply: https://www.corcept.com/careers/current-opportunities/?gh_jid=5995887004
- Excerpt: Director, Clinical Quality Assurance Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Director of Clinical Quality Assurance (CQA) is a senior member of the CQA team and will lead and perform day-to-day clinical quality operations and compliance activities to support the success of the clinical studies sponsored or supported by Corcept. This is a hybrid role typically requiring on-site presence at least 3 days per week. Responsibilities: - Lead Clinical Quality Assurance activities as line manager to assigned CQA Leads and working with therapeutic area teams to support success of the clinical studies sponsored or supported by Corcept - Champion and influence management and growth of the Clinical Quality Assurance team with the goal of attracting and developing talent, creating a rewarding professional environment, and ensuring that the team's capabilities meet Corcept's future needs - Lead, manage, and train others on GCP audits, including clinical investigative site audits, clinical

### Therapeutic Mentor - Centerstone
- Location: Bradenton, Florida (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-10
- Apply: https://centerstone.wd5.myworkdayjobs.com/CenterstoneCareers/job/Bradenton-Florida/Therapeutic-Mentor_JR-030233
- Excerpt: Therapeutic Mentor Bradenton, Florida posted: Posted 2 Days Ago

### SRA Protein Expression - Nurix Therapeutics Inc
- Location: Brisbane, CA (unspecified)
- Salary: $56-$64/hr
- Posted: 2026-05-31
- 401(k) match: listed (not source-backed)
- Apply: https://job-boards.greenhouse.io/nurix/jobs/8572314002
- Excerpt: SRA Protein Expression Brisbane, CA Company Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease. Position Summary: Research Associate III - Scientist I Protein Expression Contractor Nurix Therapeutics, Inc. is seeking a detail-oriented and experienced Protein Expression Research Associate Contractor to join the DEL and Protein Sciences team. This individual will work cross functionally with internal stakeholders to plan, coordinate, and execute all operational activities required for analytical scale and preparative scale expression of recombinant proteins in baculovirus and mammalian cell systems. Additionally, they will be responsible for documentation of expression conditions and results in internal databases and electronic lab notebook systems. This is an onsite role. Qualifications - MS or equivalent with 2+ years of relevant experience, or Ph.D. - This position requires 2+ years of experience working with insect cell lines and baculovirus expression of recombinant proteins. Additional experience working with recombinant protein expression in mammalian cells (e.g. HEK293) is a plus. Industry experience preferred with exemplified

### Vice President, Commercial Manufacturing Operations - VERA Therapeutics INC
- Location: Remote (remote)
- Salary: $248K-$375K
- Posted: 2026-06-07
- Apply: https://job-boards.greenhouse.io/veratherapeuticsinc/jobs/4273981009
- Excerpt: Vice President, Commercial Manufacturing Operations Remote Vera Therapeutics is a biotechnology company focused on developing treatments for serious immunological diseases. Vera Therapeutics' mission is to advance treatments that target the source of disease in order to change the standard of care for patients. Vera Therapeutics' lead product candidate is atacicept, a fusion protein self-administered at home as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including IgA nephropathy (IgAN) and lupus nephritis. Beyond IgAN, Vera Therapeutics is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove clinically meaningful. In addition, Vera Therapeutics holds an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B-cell-mediated diseases. Vera Therapeutics is also evaluating the development of MAU868, a monoclonal antibody designed to neutralize infection with BK virus, which can have devastating consequences in kidney transplant recipients. Vera Therapeutics retains all global developmental and commercial rights to atacicept, VT-109, and MAU868. For more information, please visit www.veratx.com . Our values are the cornerstone of our culture. Our values inspire us every day and guide everything we do-from how we hire great people, to advancing our mission together, to achieving our ultimate goal to improve medical treatment for patients suffering from immunological diseases. Position Summary: The Vice President, Manufacturing Operations will report

### Therapeutic Specialist - Gilead Sciences
- Location: Spain - Alicante (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-10
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Spain---Alicante/Therapeutic-Specialist_R0052600
- Excerpt: Therapeutic Specialist Spain - Alicante posted: Posted 2 Days Ago

### Medical Affairs Lead - Osteoarthritis - Formation Bio
- Location: NYC, NY; Boston, MA (unspecified)
- Salary: $325K-$425K
- Posted: 2026-01-14
- Apply: https://job-boards.greenhouse.io/formationbio/jobs/7475530
- Excerpt: Medical Affairs Lead - Osteoarthritis NYC, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position The Medical Affairs Lead is a first-in-function leadership role responsible for building an AI-native Medical Affairs capability across

### Senior Medical Director, Oncology - Corcept Therapeutics
- Location: Redwood City, California, United States (unspecified)
- Salary: $298K-$351K
- Posted: 2026-03-06
- 401(k) match: listed (not source-backed)
- Apply: https://www.corcept.com/careers/current-opportunities/?gh_jid=5821320004
- Excerpt: Senior Medical Director, Oncology Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . Responsibilities: - Design and implement Phase I to III clinical studies - Develop and participate in the writing and review of protocols, investigator brochures, study reports and other clinical and regulatory documents - Provide scientific oversight for Company operational staff, CROs, and clinical trial sites in all areas related to the therapeutic programs - Act as a clinical subject matter expert for both Company team members and for external contacts related to the assigned therapeutic programs - Establish and approve scientific methods for design and implementation of applicable clinical protocols, data collection systems and final reports - Act to provide medical oversight and safety monitoring for ongoing clinical trials including participation in SAE reporting and serving on the safety committee - Play a key role in the analysis, interpretation and delivery of high-quality clinical data - Interact with

### Therapeutic Specialist I - Gilead Sciences
- Location: China - Kunming (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/China---Kunming/Therapeutic-Specialist-I_R0052372-2
- Excerpt: Therapeutic Specialist I China - Kunming posted: Posted 30+ Days Ago

### Therapeutic Specialist II - Gilead Sciences
- Location: China - Shenyang (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-19
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/China---Shenyang/Therapeutic-Specialist-I_R0051136-1
- Excerpt: Therapeutic Specialist II China - Shenyang posted: Posted 24 Days Ago

### Regional Business Director, Symbravo (Southeast Region) - Axsome Therapeutics
- Location: Atlanta, GA (unspecified)
- Salary: $165K-$205K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/axsometherapeutics/jobs/5984505004
- Excerpt: Regional Business Director, Symbravo (Southeast Region) Atlanta, GA Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain's biggest problems so patients and their loved ones can flourish. For more information, please visit us at www.axsome.com and follow us on LinkedIn and X . About This Role Axsome Therapeutics is currently searching for a Regional Business Director (RBD) to lead commercial activities for an assigned geography, establish a team of Account Managers, execute marketing strategies, and ensure a successful promotion of SYMBRAVO, an oral acute migraine medication. The RBD will be primarily responsible for the supervision and leadership of an industry shaping, uniquely structured salesforce leveraging the use of a highly sophisticated digital infrastructure. All RBDs will be aligned to geographical territories and assume full ownership of driving sales within the region. The RBD is responsible for sales performance at a Region level and is expected to be a product champion and

### Patient and Community Educators - Southeast - Cogent Biosciences Inc
- Location: Remote, United States (remote)
- Salary: $190K-$225K
- Posted: 2026-04-07
- Parental leave: 12 weeks (not source-backed)
- 401(k) match: listed (not source-backed)
- Learning budget: yes (not source-backed)
- Apply: https://job-boards.greenhouse.io/cogentbiosciences/jobs/4210405009
- Excerpt: Patient and Community Educators - Southeast Remote, United States Who We Are: Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing. The Role: The Patient and Community Educator (PACE) serves as a trusted resource for individuals living with Systemic Mastocytosis (SM) and Gastrointestinal Stromal Tumor (GIST) , as well as their caregivers and community members. Reporting to the Director, Patient and Community Educators, this field-based role is responsible for delivering clear, compassionate, and compliant disease and treatment education through live and virtual engagements. The PACE team will play a critical role in empowering patients and caregivers with knowledge that helps them better understand their condition, navigate their treatment journey, and engage more confidently in conversations with their healthcare teams. This role requires a unique combination of clinical fluency, emotional intelligence, and communication expertise. The ideal candidate is

### Senior Therapeutic Specialist - Gilead Sciences
- Location: Norway - Oslo (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-13
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Norway---Oslo/Senior-Therapeutic-Specialist_R0052304-1
- Excerpt: Senior Therapeutic Specialist Norway - Oslo posted: Posted 30 Days Ago

### Senior Therapeutic Specialist II - Gilead Sciences
- Location: China - Tianjin (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/China---Tianjin/Senior-Therapeutic-Specialist-II_R0052081-1
- Excerpt: Senior Therapeutic Specialist II China - Tianjin posted: Posted 30+ Days Ago

### Senior Director, Clinical Pharmacology - Nuvalent Inc
- Location: Cambridge, MA / Remote (remote)
- Salary: $270K-$295K
- Posted: 2026-03-24
- Apply: https://boards.greenhouse.io/nuvalent/jobs/5835506004?gh_jid=5835506004
- Excerpt: Senior Director, Clinical Pharmacology Cambridge, MA / Remote The Company: With deep expertise in chemistry, Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer. Nuvalent is an exciting company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building. The Role: The Senior Director, Clinical Pharmacology will lead Nuvalent's clinical pharmacology strategy across all development programs, including late‑stage registrational efforts and emerging early‑phase assets. This leader will guide dose optimization, exposure-response modeling, regulatory strategy, and clinical pharmacology components of NDA submissions. Responsibilities: - Serve as the clinical pharmacology lead and develop and execute strategies to support Phase 1, registrational, and post‑marketing studies, including designing and leading clinical pharmacology studies. - Drive the integration of PK, PD, safety, and efficacy data to inform dose selection, dose modification, and labeling recommendations. - Lead clinical pharmacology contributions to INDs, CTAs, IBs, and NDA submissions. - Represent clinical pharmacology in interactions with FDA and other global regulators, supporting discussions related to dose justification, pediatric waivers, safety margins, and DDI strategies. - Partner closely with DMPK, Non-clinical Toxicology, Clinical Development, Biostatistics, CMC, and Regulatory Affairs to ensure cohesive end‑to‑end development plans. - Oversee population PK modeling, PK/PD modeling, and exposure-response analyses for efficacy and safety. - Guide quantitative pharmacology approaches supporting optimal dosing in patients. - Build and mentor a growing clinical pharmacology function as Nuvalent transitions from clinical‑stage to commercial‑ - Contribute to

### Veterinary Integration Lead – Therapeutic Diagnostics - Zoetis
- Location: Parsippany (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-21
- 401(k) match: listed (not source-backed)
- Apply: https://zoetis.wd5.myworkdayjobs.com/zoetis/job/Parsippany/Veterinary-Integration-Lead---Therapeutic-Diagnostics_JR00020827-1
- Excerpt: Veterinary Integration Lead – Therapeutic Diagnostics Parsippany posted: Posted 22 Days Ago

### Associate Director, Computer Systems Assurance (Quality) - Nurix Therapeutics Inc
- Location: Brisbane, CA (unspecified)
- Salary: $190K-$216K
- Posted: 2026-05-05
- 401(k) match: listed (not source-backed)
- Apply: https://job-boards.greenhouse.io/nurix/jobs/8535914002
- Excerpt: Associate Director, Computer Systems Assurance (Quality) Brisbane, CA Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix's dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine's next chapter with a new script to outmatch disease. Position The Senior Manager / Associate Director, Computer Systems Assurance (CSA) is an important technical and operational leader within the Nurix Quality Systems organization, responsible for owning and advancing Nurix's computer systems assurance program. As a virtual drug developer, Nurix operates through a lean internal infrastructure and relies on a curated ecosystem of Software-as-a-Service (SaaS) and cloud-hosted platforms to support GxP-regulated activities across clinical development, quality operations, manufacturing oversight, and regulatory submissions. This role will serve as the primary subject matter expert and program owner for all CSA and computerized system validation (CSV) activities at Nurix. Reporting to the Vice President / Senior Director, Quality Systems, this individual will establish and maintain Nurix's risk-based CSA framework aligned with current regulatory expectations, including the FDA's 2022 guidance on computer software assurance, GAMP 5 (2nd edition), and applicable 21 CFR Part 11 and Annex

### Sr Therapeutic Specialist - HIV - Gilead Sciences
- Location: Australia - Sydney (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Australia---Sydney/Sr-Therapeutic-Specialist_R0051369-2
- Excerpt: Sr Therapeutic Specialist - HIV Australia - Sydney posted: Posted 30+ Days Ago

### Senior Scientist or Principal Scientist, Targeted Proteomics - Kymera Therapeutics Inc
- Location: Watertown, MA (unspecified)
- Salary: $115K-$215K
- Posted: 2026-05-26
- 401(k) match: listed (not source-backed)
- Apply: https://www.kymeratx.com/careers-culture/working-at-kymera/?gh_jid=7748991003#open-positions
- Excerpt: Senior Scientist or Principal Scientist, Targeted Proteomics Watertown, MA Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: - PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines. - COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you'll make an impact: - Scientific Leadership and Experimental Strategy : - Partner with cross-functional project teams to define key scientific questions that can be addressed by targeted proteomics. - Collaborate with stakeholders to prioritize studies based on urgency and program impact. - Translate key program questions into

### Sr Therapeutic Specialist (愛知県) - 肝臓領域 - Gilead Sciences
- Location: Japan - Tokyo (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-12
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Japan---Tokyo/Sr-Therapeutic-Specialist------_R0052840-6
- Excerpt: Sr Therapeutic Specialist (愛知県) - 肝臓領域 Japan - Tokyo posted: Posted Today

### Senior Clinical Research Associate - Corcept Therapeutics
- Location: Redwood City, California, United States (unspecified)
- Salary: $149K-$170K
- Posted: 2026-02-05
- 401(k) match: listed (not source-backed)
- Apply: https://www.corcept.com/careers/current-opportunities/?gh_jid=5793529004
- Excerpt: Senior Clinical Research Associate Redwood City, California, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Senior Clinical Research Associate (Sr CRA) will independently manage all clinical aspects of a small to medium-sized clinical study or, with supervision, assume significant management responsibilities on a large-scale study. This position works closely with a cross-functional team, vendors, sites, and CRO (when applicable) to ensure compliance with protocol and the overall clinical objective. Additionally, this role will be responsible for implementing and monitoring clinical study activities to assure adherence to good clinical practices (GCPs), standard operating procedures (SOPs), and study protocols. This is a hybrid role typically requiring on-site presence at least 3 days per week. Responsibilities: - Serves as a crucial member of the project team for the quality execution of assigned clinical protocols according to Corcept's SOPs, ICH/GCP, and corporate and departmental program goals - Supports the Study Lead as an integral member of

### Sr Therapeutic Specialist（関西） - Gilead Sciences
- Location: Japan - Tokyo (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-03
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Japan---Tokyo/Sr-Therapeutic-Specialist--_R0052782-4
- Excerpt: Sr Therapeutic Specialist（関西） Japan - Tokyo posted: Posted 9 Days Ago

### Head, Oncology Immune Therapeutics - Novartis
- Location: Cambridge (USA) (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-21
- 401(k) match: listed (not source-backed)
- Apply: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Cambridge-USA/Head--Oncology-Immune-Therapeutics_REQ-10078504
- Excerpt: Head, Oncology Immune Therapeutics Cambridge (USA) posted: Posted 22 Days Ago

### General Interest - PostEra
- Location: Remote (remote)
- Salary: Not disclosed
- Posted: 2026-06-07
- Apply: https://jobs.lever.co/postera/f89193c2-d755-47e9-95f3-3dc1c99f41e6
- Excerpt: General Interest Remote PostEra is building a modern, 21st-century biopharma. We use Proton , our AI platform for medicinal chemistry, to accelerate the discovery of new medicines for patients. PostEra is advancing an internal pipeline focused on Women's Health and Reproductive Medicine while also advancing small-molecule programs through partnerships with biopharma. We've closed over $1Bn in AI partnerships, including four multi-year agreements with Pfizer and Amgen . We've also been an active participant in open-science projects, leading a $68M antiviral drug discovery center for pandemic preparedness, which followed on from the success of COVID Moonshot , the world's largest open-science initiative to develop a COVID antiviral. PostEra's Organizational Structure: · We believe time spent navigating complex hierarchies in organizations is better invested in the pursuit of novel technology and scientific discoveries. As such, our organizational structure is intentionally minimalist. · We promote a culture where individual achievement is celebrated through proportional compensation and internal recognition, including meaningful promotions. · Ultimately, our collective focus is delivering cures to patients, which we believe needs a huge amount of cross-disciplinary collaboration, so we've fitted our organizational structure to serve that end. If you have an interest in joining PostEra Inc, but don't see a posted position that is a perfect fit for you, feel free to submit your information here. We'll review your submission, keep it on file, and we may reach out if a position opens that we think you might be a qualified candidate for. All roles at PostEra are open

### Senior Scientist, Multiomic Therapeutics - Johnson & Johnson
- Location: 2 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-04
- 401(k) match: listed (not source-backed)
- Apply: https://jj.wd5.myworkdayjobs.com/JJ/job/Madrid-Spain/Senior-Scientist--Multiomic-Therapeutics_R-059563
- Excerpt: Senior Scientist, Multiomic Therapeutics 2 Locations posted: Posted 8 Days Ago

### Senior Director, Clinical Development - Dianthus Therapeutics
- Location: Remote (remote)
- Salary: Not disclosed
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/dianthustherapeutics/jobs/4683188005
- Excerpt: Senior Director, Clinical Development Remote About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein that drives disease pathology - enabling less frequent and more convenient self-administered subcutaneous injections. Our second clinical candidate, DNTH212 is a first and potentially best in class, bifunctional inhibitor that targets clinically validated and complementary disease modifying mechanisms, Type 1 IFN suppression and B cell modulation - enabling potential for improved clinical outcomes and patient friendly convenient, self-administered subcutaneous injections. To learn more, please visit www.dianthustx.com and follow us on LinkedIn . About the Role The Senior Medical Director, Clinical Development will be the clinical and medical strategic lead of one or more clinical trials for DNTH212. Reporting to the SVP, Clinical Development, you will steer the preparation, review and execution of clinical study synopses and protocols, investigator brochures, and clinical study reports; review SAPs and TLF shells, guide the evaluation of emerging clinical trial data, oversee/guide the data interpretation and data mining, and ensure assigned studies are conducted according to GCPs and SOPs. You will act as a the medical monitor in close collaboration with the CRO medical and clinical monitors, ensure timely recruitment in collaboration with clinical operations, oversee/guide in conducting literature searches and reviews, meta-analyses, and publishing data. You must have experience with Rare Diseases or Rheumatology within the biotechnology or pharmaceutical

### CV Therapeutic Area Lead - Amgen
- Location: South Korea - Seoul (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- Parental leave: 6 weeks (not source-backed)
- Non-birth-parent leave: 6 weeks (not source-backed)
- 401(k) match: listed (not source-backed)
- Apply: https://amgen.wd1.myworkdayjobs.com/Careers/job/South-Korea---Seoul/CV-Therapeutic-Area-Lead_R-234326-3
- Excerpt: CV Therapeutic Area Lead South Korea - Seoul posted: Posted 30+ Days Ago

### Associate Director, Analytical Development - Olema Pharmaceuticals
- Location: Boston, Massachusetts (unspecified)
- Salary: $190K-$205K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/olema/jobs/5850028004
- Excerpt: Associate Director, Analytical Development Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Associate Director, Analytical Development As the Associate Director of Analytical Development reporting to the Senior Director of Analytical Chemistry you will be responsible for driving progress of both early and late-stage molecules by delivering phase - appropriate analytical methods, validation and tech transfers. You will partner with cross-functionally supporting process development, formulations, CMC, and quality activities. In addition, you will bring demonstrated team playing and collaboration skills and experience operating effectively in a fast-paced, growth-stage biotech environment. This role can be based out of our San Francisco, CA or Boston, MA office and will require 10-15% travel . Your work will primarily encompass: Supporting analytical method development,

### Senior Therapeutic Specialist, Oncology - Gilead Sciences
- Location: 7 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Senior-Therapeutic-Specialist--Oncology_R0052354-1
- Excerpt: Senior Therapeutic Specialist, Oncology 7 Locations posted: Posted 30+ Days Ago

### Principal Scientist, Bioinformatics - Nkarta Inc
- Location: South San Francisco, California, United States (unspecified)
- Salary: $180K-$215K
- Posted: 2026-05-16
- Mental health support: yes (not source-backed)
- Apply: https://job-boards.greenhouse.io/nkartatherapeutics/jobs/5222867008
- Excerpt: Principal Scientist, Bioinformatics South San Francisco, California, United States About Us Nkarta is a publicly traded (Nasdaq symbol NKTX), clinical-stage biotechnology company headquartered in South San Francisco, focused on advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies to treat autoimmune disease. Founded in 2015, Nkarta is on a mission to harness the body's natural killer cells - the immune system's first responders - to deliver a safe, accessible form of cell therapy to treat B cell-mediated autoimmune diseases. Our vision is to make cell therapy more broadly available to patients by pioneering allogeneic NK cells that can be dosed in outpatient, community health settings. Nkarta's engineering process enhances the natural ability of NK cells to fight disease by identifying and eliminating unhealthy cells, including malfunctioning B cells at the root of many autoimmune conditions. Our lead NK cell therapy candidate, NKX019, uses NK cells collected from healthy donors rather than burdening the patient with a blood collection. Using donor-derived cells allows us to develop CAR NK cells off the shelf and on demand. Nkarta is a people-driven company looking for passionate, collaborative, determined team members galvanized by a paradigm-shifting opportunity to change the cell therapy landscape. Overview Nkarta is seeking a highly motivated, collaborative, detail-oriented Principal Scientist to join our Translational Medicine team. This is a high-impact, hands-on leadership role for a senior bioinformatics scientist. The successful candidate will have deep expertise in single-cell and spatial omics technologies, along with experience in functional genomics and leading computational

### Associate Director, Oncology Digital and Omnichannel Marketing - Corcept Therapeutics
- Location: Remote (remote)
- Salary: $172K-$228K
- Posted: 2026-06-03
- 401(k) match: listed (not source-backed)
- Apply: https://www.corcept.com/careers/current-opportunities/?gh_jid=6013629004
- Excerpt: Associate Director, Oncology Digital and Omnichannel Marketing Remote For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Associate Director, Oncology Digital and Omnichannel Marketing will play a critical leadership role in shaping and executing the digital and omnichannel marketing plan for Corcept's first oncology product, Lifyorli, in platinum-resistant ovarian cancer. Reporting to the Senior Director of Oncology Marketing, this individual will be responsible for operationalizing Corcept's omnichannel engagement model, driving seamless, data-driven customer engagement across HCP and Patient audiences. This role will drive successful execution of digital and media plans for Lifyorli, collaborating closely with Marketing, Market Access, Insights & Analytics, and IT, ensuring campaigns are measurable and continuously optimized to deliver against brand objectives. This role requires a self-starter who can effectively navigate ambiguity, brings structure to complex initiatives and proactively partners cross-functionally to translate strategy into disciplined execution. Responsibilities: Omnichannel Planning & Implementation - Collaborate on the development and execution of the operational

### Principal Scientist, Peptide Therapeutics - Genentech, Inc.
- Location: South San Francisco, California, United States of America (unspecified)
- Salary: Not disclosed
- Posted: 2026-02-24
- 401(k) match: listed (not source-backed)
- Apply: https://roche.wd3.myworkdayjobs.com/ROG-A2O-GENE/job/South-San-Francisco/Principal-Scientist--Peptide-Therapeutics_202602-103654/apply
- Excerpt: Principal Scientist, Peptide Therapeutics South San Francisco, California, United States of America This is a primarily lab-based, technical leadership position within the Peptide Therapeutics department. In this lab-based leadership role, you will combine hands-on synthetic expertise with strategic...

### Associate Director, in Vivo Pharmacology - Crinetics Pharmaceuticals INC
- Location: San Diego, CA (unspecified)
- Salary: $160K-$200K
- Posted: 2026-05-15
- 401(k) match: listed (not source-backed)
- Apply: https://crinetics.wd12.myworkdayjobs.com/CrineticsCareers/job/San-Diego-CA/Associate-Director--in-Vivo-Pharmacology_JR000625
- Excerpt: Associate Director, in Vivo Pharmacology San Diego, CA Crinetics is a pharmaceutical company based in San Diego, California, developing much-needed therapies for people with endocrine diseases and endocrine-related tumors. We were founded by a dedicated team of scientists with the simple belief that better therapies developed from rigorous innovation can lead to better lives. Our work continues to make a real difference in the lives of patients. We have a prolific discovery engine and a robust preclinical and clinical development pipeline. We are driven by science with a patient-centric and team-oriented culture. Crinetics is known for its inclusive workplace culture. We are also a dog-friendly workplace. This is an exciting time to join Crinetics as we shape our organization into the world's premier fully integrated endocrine company from discovery to patients. Join our team as we transform the lives of others. Position Summary: The Associate Director, In Vivo Pharmacology, will be responsible for providing in vivo pharmacology support to Endocrine Discovery teams including designing, conducting, and interpreting experiments to demonstrate efficacy and evaluate safety of novel nonpeptides in animal models. The candidate will have a broad background in in vivo pharmacology and will contribute to several preclinical programs as well as the identification of new therapeutic targets. Essential Job Functions and Responsibilities: These may include but are not limited to: Lead the Endocrine Discovery In Vivo Pharmacology team to plan, design, conduct, and interpret in vivo experiments to evaluate the efficacy, pharmacokinetics, and safety of therapeutic candidate molecules in support

### Information Security Lead - Click Therapeutics
- Location: New York, NY (unspecified)
- Salary: $130K-$200K
- Posted: 2026-02-25
- 401(k) match: listed (not source-backed)
- Fertility benefits: yes (not source-backed)
- Learning budget: yes (not source-backed)
- Apply: https://job-boards.greenhouse.io/clicktherapeutics/jobs/8414783002
- Excerpt: Information Security Lead New York, NY Who We Are: Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click's treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click's platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About the Role: As Information Security Lead, you'll be at the forefront of safeguarding our groundbreaking digital therapeutics. We're seeking an individual with deep technical expertise in information security in the healthcare sector, ready to tackle complex challenges and pioneer innovative solutions. This isn't just a role; it's an opportunity to build, mentor, and inspire a high-performing team, while strategically collaborating across

### Sr. Therapeutic Specialist- RA（愛知） - Gilead Sciences
- Location: Japan - Tokyo (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-25
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/Japan---Tokyo/Sr-Therapeutic-Specialist--RA--_R0049919-1
- Excerpt: Sr. Therapeutic Specialist- RA（愛知） Japan - Tokyo posted: Posted 18 Days Ago

### Director, HEOR - Definium Therapeutics
- Location: Remote (remote)
- Salary: $227K-$255K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/definiumtherapeutics/jobs/5984722004
- Excerpt: Director, HEOR Remote Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges. Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today's mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX. Together we are moving psychiatry forward-beyond better, into a boundless future. Join us! We are seeking a Director of Health Economics & Outcomes Research (HEOR) to support the development and implementation of innovative and strategically focused value evidence generation activities supporting the clinical development, commercialization, and access of Definium products in therapeutic area of brain health disorders. The candidate is responsible for designing and developing research projects, conducting analysis, reporting and publication of HEOR studies, and providing methodologic input to

### Executive Director, Investor Relations - Entrada Therapeutics Inc
- Location: Boston, MA (unspecified)
- Salary: $292K-$335K
- Posted: 2026-03-12
- 401(k) match: listed (not source-backed)
- Apply: https://job-boards.greenhouse.io/entradatherapeutics/jobs/5077431007
- Excerpt: Executive Director, Investor Relations Boston, MA The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are intellectually curious and can bring new ideas and perspectives to lead the development, implementation, and management of our

### Therapeutic Specialist - Miami North - Insmed Incorporated
- Location: Miami N, FL (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-20
- Apply: https://insmed.wd5.myworkdayjobs.com/External/job/Miami-N-FL/Therapeutic-Specialist---Miami-North_R3479
- Excerpt: Therapeutic Specialist - Miami North Miami N, FL posted: Posted 23 Days Ago

### Associate Director, Clinical Pharmacology - Crinetics Pharmaceuticals INC
- Location: Remote (remote)
- Salary: $166K-$208K
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://crinetics.wd12.myworkdayjobs.com/CrineticsCareers/job/Remote/Associate-Director--Clinical-Pharmacology_JR000603
- Excerpt: Associate Director, Clinical Pharmacology Remote Crinetics is a pharmaceutical company based in San Diego, California, developing much-needed therapies for people with endocrine diseases and endocrine-related tumors. We were founded by a dedicated team of scientists with the simple belief that better therapies developed from rigorous innovation can lead to better lives. Our work continues to make a real difference in the lives of patients. We have a prolific discovery engine and a robust preclinical and clinical development pipeline. We are driven by science with a patient-centric and team-oriented culture. Crinetics is known for its inclusive workplace culture. We are also a dog-friendly workplace. This is an exciting time to join Crinetics as we shape our organization into the world's premier fully-integrated endocrine company from discovery to patients. Join our team as we transform the lives of others. Position Summary: The Associate Director, Clinical Pharmacology will be responsible for developing clinical pharmacology strategy suitable for target product profile (TPP) and clinical development plan (CDP), leading the design, execution, interpretation, and reporting of Phase 1 clinical pharmacology studies, and serve as clinical pharmacology lead on studies and project teams. The work will support projects at various stages of development thereby allowing the selected candidate to play an active role in our drug discovery and development efforts to advance therapeutics for rare endocrine disorders and endocrine-related cancers. This is a unique opportunity to work with a proven and well-funded drug discovery and development team in a small company environment in the heart of

### Associate Director Therapeutic Area Genetics (Immunology) - Regeneron Pharmaceuticals
- Location: TARRYTOWN (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-08
- Parental leave: 12 weeks (not source-backed)
- Non-birth-parent leave: 12 weeks (not source-backed)
- 401(k) match: listed (not source-backed)
- Apply: https://regeneron.wd1.myworkdayjobs.com/Careers/job/TARRYTOWN/Associate-Director-Therapeutic-Area-Genetics--Immunology-_R46254
- Excerpt: Associate Director Therapeutic Area Genetics (Immunology) TARRYTOWN posted: Posted 4 Days Ago

### Therapeutic Area Head, Oncology - Bristol Myers Squibb
- Location: Uxbridge - GB (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-26
- 401(k) match: listed (not source-backed)
- Apply: https://bristolmyerssquibb.wd5.myworkdayjobs.com/BMS/job/Uxbridge---GB/Therapeutic-Area-Head--Oncology_R1602621
- Excerpt: Therapeutic Area Head, Oncology Uxbridge - GB posted: Posted 17 Days Ago

### Senior Director, Clinical Pharmacology - Formation Bio
- Location: New York, NY; Boston, MA (unspecified)
- Salary: $311K-$388K
- Posted: 2026-01-27
- Apply: https://job-boards.greenhouse.io/formationbio/jobs/7516264
- Excerpt: Senior Director, Clinical Pharmacology New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position Formation Bio is seeking an experienced and innovative Senior Director of Clinical Pharmacology to join our Development team.

### Therapeutic Specialist, Hepatology - BC & Saskatchewan - GSK plc
- Location: 5 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-19
- 401(k) match: listed (not source-backed)
- Apply: https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/Canada--British-Columbia--Vancouver/Therapeutic-Specialist--Hepatology---BC---Saskatchewan_439650-1
- Excerpt: Therapeutic Specialist, Hepatology - BC & Saskatchewan 5 Locations posted: Posted 24 Days Ago

### Executive Assistant, Research and Development - Protara Therapeutics INC
- Location: New York, NY (unspecified)
- Salary: $134K-$138K
- Posted: 2026-02-27
- Fertility benefits: yes (not source-backed)
- Apply: https://job-boards.greenhouse.io/protaratherapeutics/jobs/7599210003
- Excerpt: Executive Assistant, Research and Development New York, NY Company Overview: Protara Therapeutics is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara's portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin (BCG), as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral support who are otherwise unable to meet their choline needs via oral or enteral routes. Protara was named one of the Best Places to Work by BioSpace, a leading industry news and job source. This honor demonstrates the company's desirability in the recruitment marketplace, looking at various merits with an emphasis on culture, career growth and development opportunities, leadership and innovation. Attracting and retaining top talent is integral to building a successful company in biotech, and we are committed to ensuring Protara provides our employees with an exceptional experience throughout their careers, even as we continue to grow. Job Overview: Executive Assistant, Research and Development is a key member of the R&D team, and is responsible for all administrative coordination activities for the R&D organization. This is a hybrid role, and this Colleague is expected to be

### Associate Director, Analytical Development & QC - Formation Bio
- Location: New York, NY; Boston, MA (unspecified)
- Salary: $178K-$232K
- Posted: 2026-03-03
- Apply: https://job-boards.greenhouse.io/formationbio/jobs/7529162
- Excerpt: Associate Director, Analytical Development & QC New York, NY; Boston, MA About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, John Doerr, Spark Capital, SV Angel Growth, and others. You can read more at the following links: - Our Vision for AI in Pharma - Our Current Drug Portfolio - Our Technology & Platform At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently. About the Position We are seeking a highly motivated, self-driven and detail-oriented Associate Director of Analytical Development and Quality

### Therapeutic Specialist, Salt Lake City - Insmed Incorporated
- Location: 2 Locations (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-08
- Apply: https://insmed.wd5.myworkdayjobs.com/External/job/NJ-Corporate-Headquarters/Therapeutic-Specialist--Salt-Lake-City_R3512
- Excerpt: Therapeutic Specialist, Salt Lake City 2 Locations posted: Posted 4 Days Ago

### Director, Therapeutic Area Strategy, CRM - Novartis
- Location: Basel (City) (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Basel-City/Director--CRM-Therapeutic-Area-Strategy_REQ-10076215-1
- Excerpt: Director, Therapeutic Area Strategy, CRM Basel (City) posted: Posted 30+ Days Ago

### Associate Director, Patient Services - Axsome Therapeutics
- Location: New York, NY (unspecified)
- Salary: $155K-$185K
- Posted: 2026-06-04
- Apply: https://job-boards.greenhouse.io/axsometherapeutics/jobs/5779343004
- Excerpt: Associate Director, Patient Services New York, NY Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain's biggest problems so patients and their loved ones can flourish. For more information, please visit us at www.axsome.com and follow us on LinkedIn and X . About This Role Axsome Therapeutics is seeking an Associate Director, Patient Services to lead the establishment and growth of a new Patient Services Hub. This role will work closely with the Director, Patient Services for developing, implementing, and overseeing all aspects of the Hub's operations, ensuring efficient and seamless patient access to therapies and support services. This role requires a strong leader to build and manage the hub team, foster collaborative relationships, and drive continuous improvement within a fast-paced environment. This role will have close collaboration among, and provide ad hoc support to, Field Access and Patient Service functions within the Market Access team, as related to the HUB.

### Senior Director, Product Marketing - Atricure
- Location: Mason, OH; Minnetonka, MN (unspecified)
- Salary: $200K-$275K
- Posted: 2026-06-12
- 401(k) match: listed (not source-backed)
- Apply: https://job-boards.greenhouse.io/atricure/jobs/4281191009
- Excerpt: Senior Director, Product Marketing Mason, OH; Minnetonka, MN AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure's Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure's AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure's Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure's cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure. We foster a culture of inclusion by embracing diverse experiences and individuals where everyone's authentic self is welcome. We offer supporting programs and resources that provide enriching and equitable opportunities for each person to contribute professionally and personally. POSITION SUMMARY: The Senior Director, Product Marketing is responsible for owning and advancing the overall strategy, growth, and performance of the Pain Management portfolio. This role leads the business case for sustained portfolio growth, owns enterprise ‑ level portfolio and lifecycle strategy, and drives both upstream innovation and downstream commercialization initiatives across the pain management therapy area. The position serves as the primary voice and champion for Pain Management, shaping the long

### Therapeutic Specialist, HCV/PBC -- Macon/Savannah - Gilead Sciences
- Location: United States - Field (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- 401(k) match: listed (not source-backed)
- Apply: https://gilead.wd1.myworkdayjobs.com/gileadcareers/job/United-States---Field/Sr-Therapeutic-Specialist--HCV-PBC----Macon-Savannah_R0050403
- Excerpt: Therapeutic Specialist, HCV/PBC -- Macon/Savannah United States - Field posted: Posted 30+ Days Ago

### Vice President, Clinical Development - Septerna Inc
- Location: South San Francisco, California, United States (unspecified)
- Salary: $380K-$420K
- Posted: 2026-04-12
- Apply: https://job-boards.greenhouse.io/septerna/jobs/5185908008
- Excerpt: Vice President, Clinical Development South San Francisco, California, United States Septerna is a biotechnology company based in South San Francisco, CA on a mission to develop life-changing medicines for patients with the vision to become the industry-leading G protein-coupled receptor (GPCR)-focused drug discovery company. The company's Native Complex Platform™ recapitulates GPCRs with their native structure, function, and dynamics outside of the cellular context. This approach enables novel access to modern structural and screening technologies used in industrial-scale drug discovery for the entire class of GPCRs. Septerna has an emerging pipeline of GPCR-targeted small molecule programs with potential for growth to target many GPCRs that have been undruggable and unexploited to date. We are excited to expand our multidisciplinary team of individuals focused on creating revolutionary medicines to address the unmet needs of patients. At Septerna we strive to embrace diversity of thought, expertise, and background through collaboration. To join our ambitious team, be prepared to bring your real self to work every day; grow and learn from a talented team of drug hunters, scientists, and business professionals; and contribute your passion, creativity, and energy to accomplish our mission. We share a fearless pursuit of ground-breaking innovations and cultivate an environment where our employees succeed by learning from each other and working as a team. We are committed to the development of meaningful therapeutics for patients with indications of high unmet need. This is a tremendous opportunity to work with talented individuals on the frontlines of therapeutic discovery and development. You

### Therapeutic Specialist - Northern Houston - Insmed Incorporated
- Location: North Houston, TX (unspecified)
- Salary: Not disclosed
- Posted: 2026-05-12
- Apply: https://insmed.wd5.myworkdayjobs.com/External/job/North-Houston-TX/Therapeutic-Specialist---Northern-Houston_R3236
- Excerpt: Therapeutic Specialist - Northern Houston North Houston, TX posted: Posted 30+ Days Ago

### Senior Clinical Trial Associate (CONTRACT) - Entrada Therapeutics Inc
- Location: Boston, MA (unspecified)
- Salary: Not disclosed
- Posted: 2026-06-04
- 401(k) match: listed (not source-backed)
- Apply: https://job-boards.greenhouse.io/entradatherapeutics/jobs/5155427007
- Excerpt: Senior Clinical Trial Associate (CONTRACT) Boston, MA The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are patient focused and excited about the opportunity to help support and develop the Clinical Operations organization at

---
Source-backed benefit claims include source links; other benefit values are labeled separately.